Predicting Clostridium difficile stool cytotoxin results in hospitalized patients with diarrhea

Journal of General Internal Medicine

Volumn 12, Issue 1, 1997, Pages 57-62

  Katz, David A ^a,e   Bates, David W ^b   Rittenberg, Eve ^b   Onderdonk, Andrew ^c   Sands, Kenneth ^d   Barefoot, Laurie A ^a   Snydman, David ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e Section of General Internal Medicine   (United States)

Author keywords

Clostridium difficile; quality of care; routine diagnostic tests; utilization

Indexed keywords

CLOSTRIDIUM TOXIN; CYTOTOXIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG USE; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; TOXIN ANALYSIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; CYTOTOXINS; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 0031043540     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11606-006-0008-0     Document Type: Article

References (36)

1. Fekety R. Antibiotic-associated colitis. In: Mandell G, Douglas R, Bennett J, eds. Principles and Practice of Infectious Disease. New York, NY: Churchill Livingstone; 1990.
2. Kofsky P, Rosen L, Reed J, Tolmie M, Ufberg D. Clostridium difficile - a common and costly colitis. Dis Colon Rectum. 1991;34: 244-8.
3. Yablon S, Krotenberg R, Fruhmann K. Clostridium difficile-related disease: evaluation and prevalence among inpatients with diarrhea in two freestanding rehabilitation hospitals. Arch Phys Med Rehabil. 1993;74:9-13.
4. Chang T, Lauermann M, Bartlett J. Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis. 1979;140(5):760-70.
5. Katz D, Lynch M, Littenberg B. Clinical predictors of Clostridium difficile stool cytotoxin results in hospitalized patients with diarrhea. Am J Med. 1996;100:487-95.
6. Siegel D, Edelstein P, Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA. 1990;263(7):979-82.
7. Koplan J, Fineberg H, Ferraro M, Rosenberg M. Value of stool cultures. Lancet. 1980;2(8191):413-6.
8. Fan K, Morris A, Reller L. Application of refection criteria for stool cultures for bacterial enteric pathogens. J Clin Microbiol. 1993;31:2233-5.
9. Yannelli B, Gurevich I, Schoch P, Cunha B. Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrheas. Am J Infect Control. 1988;16:246-9.
10. Bowman R, Riley T. Routine culturing for Clostridium difficile? Pathology. 1984;16:240-2.
11. Renshaw AA, Stelling JM, Doolittle MH. The lack of value of repeated Clostridium difficile cytotoxicity assays. Arch Pathol Lab Med. 1996;120:49-52.
12. Centor R, Yarbrough B, Wood J. Inability to predict relapse in acute asthma. N Engl J Med. 1984;310:577-80.
13. Rose C, Murphy J, Schwartz J. Performance of an index predicting the response of patients with acute bronchial asthma to intensive emergency department treatment. N Engl J Med. 1984;310:573-7.
14. Manabe Y, Vinetz J, Moore R, et al. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med. 1995;123:835-40.
15. Sleisenger M, Fordtran J, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 4th ed. Philadelphia, PA: WB Saunders; 1989.
16. Kamthan A, Bruckner H, Hirschman S, Agus S. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med. 1992;152(8):1715-7.
17. McFarland L, Surawicz C, Stamm W. Risk factors of Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162(3):678-84.
18. Hanley J, McNeil B. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-43.
19. Centor R. A Visicalc program for estimating the area under the receiver operating characteristic (ROC) curve. Med Decis Making. 1985;5:139-48.
20. Bowman R, Bowman J, Arrow S, Riley T. Selective criteria for the microbiological examination of faecal specimens. J Clin Pathol. 1992;45:838-9.
21. Bartlett J, Willey S, Chang T, Lowe B. Cephalosporin-associated pseudomembranous colitis due to Clostridium difficile. JAMA. 1979;242:2683-5.
22. Zimmerman R. Risk factors for Clostridium difficile cytotoxin-positive diarrhea after control for horizontal transmission. Infect Controt Hosp Epidemiol. 1991;12:96-100.
23. Thibault A, Miller M, Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol. 1991;12:345-8.
24. Jobe B, Grasley A, Deveney K, Deveney C, Sheppard B. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg. 1995;169:480-3.
25. Gerding D, Olson M, Peterson L, et al. Clostridium difficile-associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med. 1986;146:95-100.
26. Bartlett J. Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea or colitis. Johns Hopkins Med J. 1981;149:6-12.
27. Brown E, Talbot G, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol. 1990;11(6):283-90.
28. Pear S, Williamson T, Gettin K, Gerding D, Galgiani J. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med. 1994;120(4):272-7.
29. Jensen G, Bross J, Bourbeau P, et al. Risk factors for Clostridium difficile stool cytotoxin b among critically ill patients: role of sucralfate. J Infect Dis. 1994;170:227-30.
30. Clabots C, Johnson S, Olson M, Peterson L, Gerding D. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis. 1992;166(3):561-7.
31. Samore M, Bettin K, DeGirolami P, et al. Wide diversity of Clostridium difficile types at a tertiary referral hospital. J infect Dis. 1994;170(3):615-21.
32. Lyerly D, Krivan H, Wilkins T. Clostridium difficile: its disease and toxins. Clin Microbiol Rev. 1988;1(1):1-18.
33. Maniar AC, Williams T, Hammond G. Detection of Clostridium difficile toxin in various tissue culture monolayers. J Clin Microbiol. 1987;25(10):1999-2000.
34. Fekety R. Diagnosis and treatment of Clostridium difficile colitis. JAMA. 1993;269(1):71-5.
35. Poses R, Cebul R, Collins M, Fager S. The importance of disease prevalence in transporting clinical prediction rules: the case of streptococcal pharyngitis. Ann Intern Med. 1986;105:586-91.
36. Sox H Jr, Blatt M, Higgins M, Marton K. Medical Decision Making. Boston, Mass: Butterworths; 1988.